Trial Profile
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Carbamazepine; Gabapentin; Lamotrigine; Levetiracetam; Lithium; Oxcarbazepine; Valproic acid
- Indications Anxiety; Bipolar disorders; Depressive disorders; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- 29 Jul 2011 New trial record